March 18, 1999
Institute Of Medicine
Marijuana's active components are potentially effective in treating pain, nausea, the anorexia of AIDS wasting, and other symptoms, and should be tested rigorously in clinical trials, according to a new report from the Institute of Medicine (IOM). Such trials should be carried out in parallel with the development of new delivery mechanisms for the drug that are safe, fast-acting, and reliable, but do not involve inhaling harmful smoke, the report says. Moreover, it adds, clinical trials of marijuana use should be approved by institutional review boards, and should involve only short-term use among patients who are most likely to benefit from treatment.
Clinical Trials, Drug Development Should Proceed, Experts Advise
The above story is based on materials provided by Institute Of Medicine. Note: Materials may be edited for content and length.
Cite This Page:
Institute Of Medicine. "Marijuana's Components Have Potential As Medicine, According To New Federal Report." ScienceDaily. ScienceDaily, 18 March 1999. <www.sciencedaily.com/releases/1999/03/990318042646.htm>.
Institute Of Medicine. (1999, March 18). Marijuana's Components Have Potential As Medicine, According To New Federal Report. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/1999/03/990318042646.htm
Institute Of Medicine. "Marijuana's Components Have Potential As Medicine, According To New Federal Report." ScienceDaily. www.sciencedaily.com/releases/1999/03/990318042646.htm (accessed April 23, 2014).